[1]CurrentPatentAssignee:CHDIFOUNDATION-WO2013/33085,2013,A1
[2]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-US2021/386721,2021,A1
[3]CurrentPatentAssignee:YANGTZERIVERPHARMACEUTICALGROUPCOLTD-US2021/386721,2021,A1
1239489-82-7
19219-99-9
5676-56-2
1195693-72-1
55202-46-5
126892-02-2
1698267-51-4 | (4-bromo-1-methyl-1H-1,2,3-triazol-5-yl)methanol | AA01ALFJ | MFCD28968203
1803606-83-8 | (2-ethyl-4-methyl-1,3-oxazol-5-yl)methanamine hydrochloride | AA01ALKO | MFCD28954414
1314938-98-1 | 3,5-dimethylthiophene-2-sulfonyl chloride | AA01ALQ5 | MFCD19201091
1502312-69-7 | (3-methylbicyclo[3.1.0]hexan-3-yl)methanol | AA01ALVC | MFCD23908545
1343359-94-3 | 3-Bromo-5-fluoroisatoic anhydride | AA01ALZB | MFCD18269603
1803585-70-7 | ethyl 8-fluoro-2-oxa-6-azaspiro[3.4]octane-8-carboxylate hydrochloride | AA01AM3U | MFCD28968386
1785589-49-2 | 2-methoxybutane-1-sulfonyl chloride | AA01AM7M | MFCD29060250
1864053-29-1 | tert-butyl 2-(azepan-4-yl)acetate hydrochloride | AA01AML3 | MFCD29033952
1488263-56-4 | 2-cyclopropyl-2-methoxyethan-1-amine | AA01AMRD | MFCD21684725
62773-65-3 | Ethyl 5-amino-2-hydroxybenzoate | AA01AMW2 | MFCD11042850